Hastings Cent Rep. 2021 May;51(3):13-17. doi: 10.1002/hast.1256.
Though questions about whether gene editing should be done at all have dominated ethical discussion, a literature about how it can be done ethically has been growing. Work on responsible translational pathways for human germline gene editing has been criticized for focusing on the wrong questions. But questions about responsible translational pathways-questions about how gene editing could be done ethically-are, in an important sense, prior to questions about whether it is desirable and permissible. Asking "whether" questions about gene editing requires a model of what responsible clinical use of gene editing would look like.
虽然有关是否应该进行基因编辑的问题一直主导着伦理讨论,但关于如何在伦理上进行基因编辑的文献一直在不断增加。人类生殖系基因编辑的负责任转化途径的研究工作因专注于错误的问题而受到批评。但是,关于负责任的转化途径的问题——关于如何在伦理上进行基因编辑的问题——在重要意义上先于是否可取和允许的问题。提出关于基因编辑的“是否”问题需要一个模型,说明负责任的临床使用基因编辑将是什么样子。